---
layout: post
title: ITPR2
date: 2025-01-17 16:55 CST
description: ITPR2 description
tags: [cooccuring-genes]
categories: unknown-mechanism
pretty_table: true
citation: true
related_posts: true
---



| [NCBI ID](https://www.ncbi.nlm.nih.gov/gene/3709) | NCBI symbol | ENSEMBL ID | Chromosome location |
| :-------- | :------- | :-------- | :------- |
| 3709  | ITPR2 | ENSG00000123104 | 12p11.23 |



The gene is involved in [response to hypoxia](https://amigo.geneontology.org/amigo/term/GO:0001666) and [signal transduction](https://amigo.geneontology.org/amigo/term/GO:0007165), including [calcium-mediated signaling](https://amigo.geneontology.org/amigo/term/GO:0019722). It enables [inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity](https://amigo.geneontology.org/amigo/term/GO:0005220), [calcium ion binding](https://amigo.geneontology.org/amigo/term/GO:0005509), [calcium ion transmembrane transporter activity](https://amigo.geneontology.org/amigo/term/GO:0015085), [phosphatidylinositol binding](https://amigo.geneontology.org/amigo/term/GO:0035091), [transmembrane transporter binding](https://amigo.geneontology.org/amigo/term/GO:0044325), [inositol 1,4,5 trisphosphate binding](https://amigo.geneontology.org/amigo/term/GO:0070679), and [scaffold protein binding](https://amigo.geneontology.org/amigo/term/GO:0097110). It is located in the [nucleoplasm](https://amigo.geneontology.org/amigo/term/GO:0005654), [endoplasmic reticulum](https://amigo.geneontology.org/amigo/term/GO:0005783), [endoplasmic reticulum membrane](https://amigo.geneontology.org/amigo/term/GO:0005789), [plasma membrane](https://amigo.geneontology.org/amigo/term/GO:0005886), [cell cortex](https://amigo.geneontology.org/amigo/term/GO:0005938), [membrane](https://amigo.geneontology.org/amigo/term/GO:0016020), [sarcoplasmic reticulum](https://amigo.geneontology.org/amigo/term/GO:0016529), [secretory granule membrane](https://amigo.geneontology.org/amigo/term/GO:0030667), [platelet dense tubular network membrane](https://amigo.geneontology.org/amigo/term/GO:0031095), and [sarcoplasmic reticulum membrane](https://amigo.geneontology.org/amigo/term/GO:0033017). Additionally, it is part of the [receptor complex](https://amigo.geneontology.org/amigo/term/GO:0043235) and is active in the [endoplasmic reticulum membrane](https://amigo.geneontology.org/amigo/term/GO:0005789), [plasma membrane](https://amigo.geneontology.org/amigo/term/GO:0005886), [sarcoplasmic reticulum](https://amigo.geneontology.org/amigo/term/GO:0016529), and [secretory granule membrane](https://amigo.geneontology.org/amigo/term/GO:0030667). The gene is also involved in the [release of sequestered calcium ion into cytosol](https://amigo.geneontology.org/amigo/term/GO:0051209), [cellular response to cAMP](https://amigo.geneontology.org/amigo/term/GO:0071320), and [cellular response to ethanol](https://amigo.geneontology.org/amigo/term/GO:0071361).


The gene length is 83,554 base pairs (78.33rd percentile), the mature length is 4,887 base pairs (89.75th percentile), and the primary transcript length is 83,554 base pairs (85.58th percentile).


The gene ITPR2 (NCBI ID: 3709) has been mentioned in [25 publications](https://pubmed.ncbi.nlm.nih.gov/?term=%22ITPR2%22) according to [Pubtator](https://academic.oup.com/nar/article/47/W1/W587/5494727), with the earliest publication in 2007 and the middle 50% of publications occurring between 2014 and 2020. Note that the publication count in the hyperlink may be different since the count is from Pubtator.


The top 5 publications mentioning ITPR2, ranked by their scientific influence, include "[Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence.](https://pubmed.ncbi.nlm.nih.gov/24797322)" (2014) with a [Relative Citation Ratio (RCR)](https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002541) of 4.2, "[ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.](https://pubmed.ncbi.nlm.nih.gov/17827064)" (2007) with an RCR of 3.43, "[IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2.](https://pubmed.ncbi.nlm.nih.gov/23681227)" (2013) with an RCR of 2.68, "[Astrocytic IP<sub>3</sub>Rs: Beyond IP<sub>3</sub>R2.](https://pubmed.ncbi.nlm.nih.gov/34393726)" (2021) with an RCR of 2.17, and "[Abolished InsP3R2 function inhibits sweat secretion in both humans and mice.](https://pubmed.ncbi.nlm.nih.gov/25329695)" (2014) with an RCR of 2.02. The Relative Citation Ratio (RCR) measures the scientific influence of each paper by field- and time-adjusting the citations it has received, benchmarking to the median for NIH publications, which is set at 1.0. Citation counts are sourced from [iCite](https://icite.od.nih.gov).


[ITPR2](https://www.proteinatlas.org/ENSG00000123104-ITPR2) is a gene encoding a protein with molecular functions as a calcium channel, ion channel, ligand-gated ion channel, and receptor. It is involved in disease variants and has evidence at the protein level. The gene is detected in all tissues, with notable expression in the nucleoplasm, endoplasmic reticulum, and various parts of the spermatozoa. It is associated with specific expression clusters in basophils, liver, brain, ciliated cells, and oligodendrocyte precursors.


The top transcription factors (TFs) identified from the GTRD database of TF binding sites, based on the number of CHIP-seq experiments, include [HDAC2](https://www.ncbi.nlm.nih.gov/gene/3066), [MYC](https://www.ncbi.nlm.nih.gov/gene/4609), [ZBTB7A](https://www.ncbi.nlm.nih.gov/gene/51341), and [MAX](https://www.ncbi.nlm.nih.gov/gene/4149), each with 5 experiments. Additionally, [ESR1](https://www.ncbi.nlm.nih.gov/gene/2099) was found to be regulating in 4 experiments.



The input data from GWAS indicates associations with a wide range of disease conditions, including various types of cancer such as breast cancer, thoracic cancer, reproductive organ cancer, gastrointestinal system cancer, lung cancer, leukemia, lymphoma, and immune system cancer. Additionally, the data highlights metabolic disorders like diabetes mellitus, type 2 diabetes mellitus, obesity, and cardiovascular diseases such as coronary artery disease, hypertension, and arteriosclerosis. Neurodegenerative diseases, including Alzheimer's disease and dementia, are also represented, along with mental health conditions like bipolar disorder, mood disorder, and substance dependence. Other notable conditions include musculoskeletal system diseases, sensory system diseases, anemia, and specific developmental disorders like attention deficit hyperactivity disorder. The data further includes specific cancer types such as uterine cancer, endometrial cancer, glioblastoma multiforme, renal cell carcinoma, and non-small cell lung carcinoma, as well as lymphatic system diseases like elephantiasis and lymphedema.


The gene ITPR2 has been associated with [Low density lipoprotein cholesterol levels](https://pubmed.ncbi.nlm.nih.gov/32493714), which maps closely to the MeSH term [Lipoproteins](https://meshb.nlm.nih.gov/record/ui?ui=D008074) using the [BioWordVec](https://www.nature.com/articles/s41597-019-0055-0) method. Additionally, ITPR2 is linked to [Total cholesterol levels](https://pubmed.ncbi.nlm.nih.gov/34594039), with the closest MeSH match being [Cholesterol](https://meshb.nlm.nih.gov/record/ui?ui=D002784), also identified through embedding matching.


The gene is expressed in various tissues, including the salivary gland and adrenal gland, according to BioGPS Human Cell Type and Tissue Gene Expression Profiles. Additionally, GTEx Tissue Gene Expression Profiles indicate expression in cardiac myocytes, heart, salivary gland, superior cervical ganglion, trigeminal ganglion, skeletal muscle, and skin.


The input data highlights various pathways involving proteins, including metabolism, beta-catenin independent WNT signaling, and signaling by Wnt. Additionally, it covers VEGFR2-mediated cell proliferation and multiple aspects of the immune system, such as the adaptive and innate immune systems, as well as DAP12 interactions and signaling. The data also encompasses signaling by various growth factors and receptors, including PDGF, FGFR, ERBB2, EGFR, and VEGF. Furthermore, it includes pathways related to NGF signaling, B Cell Receptor (BCR) signaling, and Fc epsilon receptor (FCERI) signaling. Metabolic regulation, such as glucagon-like peptide-1 (GLP1) regulation of insulin secretion and integration of energy metabolism, is also noted. The data extends to G-protein coupled receptor (GPCR) signaling, signal transduction, and phospholipase C-mediated cascades. Additionally, it covers opioid signaling, platelet homeostasis, and hemostasis, including platelet activation, signaling, and aggregation.



The analyzed protein sequence has a GRAVY value of -0.267 (61.83rd percentile), indicating a hydrophilic nature. The charge at pH 7.0 is -36.22 (4.55th percentile), and the median structural flexibility is 0.998 (32.57th percentile). The protein has a length of 2701 amino acids (98.91st percentile) and a molecular weight of 308060.2 Da (99.01st percentile). The secondary structure affinities are 32.95% for helix (58.96th percentile), 37.54% for sheet (76.09th percentile), and 26.29% for turn (31.74th percentile). The instability index is 40.06 (22.42nd percentile), and the isoelectric point is 6.01 (30.81st percentile). For more details on the sequence analysis, refer to the [BioPython documentation](https://biopython.org/docs/1.75/api/Bio.SeqUtils.ProtParam.html).





| Checks    | Answer |
| :-------- | :------- |
| Sentiment  | neutral   |
| Ethical concerns | no     |
| Coherence    | no    |